DexCom, Inc. (DXCM) income statement
NASDAQ · Healthcare · Medical - Devices · 11,050 employees · CEO Jacob Steven Leach
- Price
- $82.29 +2.95%
- Market cap
- $30.7B
- Enterprise value
- $31.1B
- Last report
- Q3 '26 filed 2026-10-29
- Next report
- 2027-02-11 EPS est. $0.72
DexCom, Inc. (DXCM) reported revenue of $1.34B for Q3 '26 (+11.2% year on year), operating income of $327M (24.3% of revenue) and net income of $275M. Over the last four quarters revenue was $5.1B.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.03B | $921M | $1B | $994M | $1.11B | $1.04B | $1.16B | $1.21B | $1.26B | $1.19B | $1.31B | $1.34B | |
| Cost of revenue | $378M | $359M | $378M | $400M | $458M | $447M | $468M | $478M | $467M | $442M | $478M | $480M | |
| Gross profit | $657M | $562M | $627M | $594M | $656M | $589M | $689M | $731M | $793M | $750M | $830M | $864M | |
| Research & development | $136M | $142M | $136M | $135M | $140M | $145M | $148M | $158M | $148M | $145M | $153M | $162M | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $376M | |
| Other operating expenses | -$5.2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating expenses | $440M | $461M | $469M | $442M | $467M | $455M | $476M | $489M | $470M | $495M | $512M | $537M | |
| Operating income | $217M | $101M | $158M | $152M | $189M | $134M | $213M | $243M | $323M | $255M | $318M | $327M | |
| Interest income | $33.8M | $36.3M | $36.2M | $32M | $29.7M | $28.5M | $28M | $32.7M | $23.5M | $19.5M | $16.9M | $14.3M | |
| Interest expense | $4.9M | $4.6M | $4.8M | $4.7M | $4.9M | $4.7M | $4.7M | $4.7M | $4.2M | $3.1M | $3M | $3.1M | |
| Other non-operating income (gains on investments, FX ...) | -$34.2M | -$36M | -$34.6M | -$30.1M | -$27.3M | -$25.3M | -$33.2M | -$115M | -$21.9M | -$17.3M | -$2.2M | -$10.6M | |
| Total non-operating income | $29.3M | $31.4M | $29.8M | $25.4M | $22.4M | $20.6M | $28.5M | $110M | $17.7M | $14.2M | -$800K | $7.5M | |
| Income before tax | $246M | $133M | $188M | $177M | $211M | $154M | $241M | $352M | $341M | $270M | $318M | $335M | |
| Income tax | -$10.1M | -$13.9M | $44.3M | $42.8M | $59.6M | $48.9M | $61.3M | $68.5M | $73.4M | $70M | $68.4M | $59.6M | |
| Net income | $256M | $146M | $144M | $135M | $152M | $105M | $180M | $284M | $267M | $200M | $249M | $275M | |
| EPS (basic) | $0.67 | $0.38 | $0.36 | $0.35 | $0.39 | $0.27 | $0.46 | $0.73 | $0.69 | $0.52 | $0.65 | $0.73 | |
| EPS (diluted) | $0.62 | $0.36 | $0.35 | $0.34 | $0.38 | $0.27 | $0.45 | $0.70 | $0.68 | $0.51 | $0.64 | $0.72 | |
| Shares (basic, weighted) | 384M | 390M | 399M | 394M | 399M | 391M | 392M | 391M | 387M | 385M | 384M | 375M | |
| Shares (diluted, weighted) | 416M | 417M | 417M | 410M | 407M | 408M | 408M | 407M | 399M | 394M | 392M | 384M | |
| Depreciation & amortization | $52.5M | $52.5M | $52.1M | $55.3M | $57.8M | $60M | $63M | $63.6M | $65.2M | $67.1M | $68.2M | $74.5M | |
| EBITDA | $304M | $190M | $245M | $237M | $274M | $219M | $309M | $421M | $410M | $340M | $389M | $412M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $573M | $719M | $1.03B | $1.48B | $1.93B | $2.45B | $2.91B | $3.62B | $4.03B | $4.66B | |
| Cost of revenue | $195M | $226M | $368M | $545M | $647M | $768M | $1.03B | $1.33B | $1.59B | $1.86B | |
| Gross profit | $378M | $492M | $664M | $932M | $1.28B | $1.68B | $1.88B | $2.29B | $2.44B | $2.8B | |
| Research & development | $156M | $185M | $417M | $274M | $360M | $604M | $484M | $506M | $552M | $599M | |
| Operating expenses | $442M | $535M | $850M | $789M | $981M | $1.41B | $1.49B | $1.69B | $1.84B | $1.89B | |
| Operating income | -$63.9M | -$42.5M | -$186M | $142M | $300M | $266M | $391M | $598M | $600M | $912M | |
| Interest income | $400K | $6.7M | $2.4M | $26.4M | $16.1M | $1.7M | $23.8M | $135M | $134M | $113M | |
| Interest expense | $700K | $12.8M | $22.7M | $60.3M | $84.7M | $18.8M | $18.6M | $20.3M | $19M | $18.3M | |
| Other non-operating income (gains on investments, FX ...) | $300K | -$6.7M | -$82.5M | -$22.2M | -$10.2M | -$9.8M | -$18.2M | -$133M | -$128M | -$195M | |
| Total non-operating income | -$1M | -$6.1M | $59.8M | -$38.1M | -$74.5M | -$9M | -$400K | $113M | $109M | $177M | |
| Income before tax | -$64.9M | -$48.6M | -$127M | $104M | $225M | $257M | $391M | $710M | $709M | $1.09B | |
| Income tax | $700K | $1.6M | $600K | $3.1M | -$269M | $39.9M | $49.6M | $169M | $133M | $252M | |
| Net income | -$65.6M | -$50.2M | -$127M | $101M | $494M | $217M | $341M | $542M | $576M | $836M | |
| EPS (basic) | -$0.20 | -$0.15 | -$0.36 | $0.28 | $1.31 | $0.56 | $0.88 | $1.44 | $1.46 | $2.14 | |
| EPS (diluted) | -$0.20 | -$0.15 | -$0.36 | $0.27 | $1.27 | $0.51 | $0.80 | $1.30 | $1.42 | $2.09 | |
| Shares (basic, weighted) | 334M | 345M | 353M | 364M | 378M | 387M | 389M | 386M | 405M | 390M | |
| Shares (diluted, weighted) | 334M | 345M | 353M | 369M | 390M | 429M | 428M | 426M | 413M | 406M | |
| Depreciation & amortization | $15M | $16.1M | $29.1M | $48.7M | $67.1M | $102M | $156M | $186M | $218M | $252M | |
| EBITDA | -$49.2M | -$19.7M | -$74.7M | $213M | $377M | $378M | $565M | $917M | $946M | $1.36B |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-02